GlassScriptPhysician profile
Jeffrey Spencer
NPI 1861802373
$430,140.31
in general payments reported to CMS, 2019-2025
20 companies · $70.84 in 2025
The $70.84 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $198 · 2020: $115 · 2021: $135 · 2022: $1,366 · 2023: $37K · 2024: $391K · 2025: $70.84.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $428K · Food and Beverage: $311 · Education: $65.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $427,950.00 |
| Food and Beverage | $311.09 |
| Education | $65.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verathon INC. | $428,950.00 | 2022-2024 | Npd Clinical Study |
| Coloplast Corp | $243.42 | 2019-2024 | |
| Medtronic, INC. | $123.84 | 2021 | |
| Olympus America INC. | $117.92 | 2019-2022 | |
| Calyxo, INC. | $110.51 | 2024-2025 | Cvac Aspiration System |
| Astellas Pharma US INC | $100.56 | 2019-2023 | |
| Neotract INC. | $100.28 | 2020 | |
| Abbvie INC. | $84.25 | 2022-2023 | Botox |
| Endo Pharmaceuticals INC. | $72.43 | 2022 | |
| Dendreon Pharmaceuticals LLC | $55.00 | 2022 | |
| Sumitomo Pharma America, INC. | $32.14 | 2023-2024 | Gemtesa |
| Tolmar Pharmaceuticals, INC. | $23.03 | 2022 | |
| Myriad Genetic Laboratories, INC. | $21.22 | 2022 | |
| Allergan, INC. | $18.15 | 2022 | |
| Janssen Biotech, INC. | $16.95 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $15.17 | 2022 | |
| Teleflex LLC | $14.96 | 2022 | |
| Antares Pharma, INC. | $14.85 | 2020 | |
| Myovant Sciences INC. | $14.33 | 2022 | |
| Axonics, INC. | $11.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Spencer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.